Efficacy of Minnelide in a Next-Generation Dual-Recombinase Regulated Genetically Engineered Mouse Model of CIC::DUX4 Sarcoma
MaKenna R. Browne, Axel V Silver, Risha Banerjee, Kristianne Michelle Oristian, Jonathon E. Himes, Peter G. Hendrickson, David G. Kirsch
This paper develops a new mouse model of CIC::DUX4 sarcoma and identifies Minnelide as a selective inhibitor effective in preclinical models.
bioRxiv · Nov 6, 2025 · PreprintCancer Biology